Journal article icon

Journal article

Etanercept for the treatment of rheumatoid arthritis.

Abstract:

BACKGROUND: Etanercept is a soluble tumour necrosis factor alpha-receptor DMARD for the treatment of rheumatoid arthritis (RA). OBJECTIVES: To assess the efficacy and safety of etanercept for the treatment of RA. SEARCH STRATEGY: Five electronic databases were searched from 1966 to February 2003 with no language restriction. SELECTION CRITERIA: All randomized controlled trials (minimum 6 month duration) comparing three possible combinations 1) etanercept (10 mg or 25 mg twice weekly) with me...

Expand abstract

Actions


Access Document


Publisher copy:
10.1002/14651858.cd004525

Authors


Blumenauer, B More by this author
Cranney, A More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Primary Care Health Sciences, PHC-EBM
Expand authors...
Journal:
The Cochrane database of systematic reviews
Volume:
5
Issue:
4
Pages:
CD004525
Publication date:
2003
DOI:
EISSN:
1469-493X
URN:
uuid:058d53eb-8716-4b50-95cf-5b1beaa0da06
Source identifiers:
116346
Local pid:
pubs:116346

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP